Moreover, FL118 exhibits its remarkable efficacy independent of p53 status (wild-type, mutant, or null) in cells, and, thus, it stands as a potent therapeutic agent for cancers characterized by p53 dysfunction, in which most DNA damage drugs (if not all) show a remarkable lack of efficiency [13,16]. The gene discussed is TP53; the disease is cancer.